Princeton Bancorp (BPRN) Insider Tuchman Buys $13K of Stock

Martin Tuchman, a notable investor, recently increased his stake in BPRN by purchasing 355 shares on June 12, 2026. He bought these shares at an average price of $37.29, bringing the total transaction value to $13,237.95. This move reflects Tuchman's ongoing interest in the company.

Insider Buying and Selling at Princeton Bancorp, Inc.

Several insiders have been active in acquiring BPRN shares recently. Martin Tuchman made multiple purchases, including 663 shares on June 16, 2026, at $37.70 each, and 46 shares on June 15, 2026, at $37.65 each. Other insiders like Judith Giacin, Richard Gillespie, and Robert Ridolfi also bought 663 shares each on June 16, 2026, at the same price of $37.70.

Other Institutional Activity in BPRN

Institutional investors have also been making moves with BPRN. AllianceBernstein L.P. reduced its holdings by 9,918 shares, ending with 560,539 shares valued at approximately $19.45 million, showing a 1.7% decrease. BlackRock, Inc. trimmed its position slightly by 1,578 shares to hold 368,310 shares worth about $12.44 million. Vanguard Capital Management LLC opened a new position with 251,335 shares valued at $8.49 million. Systematic Financial Management LP significantly cut its stake by 71,145 shares, leaving it with 238,887 shares valued at $8.07 million, a 22.9% decrease. Dimensional Fund Advisors LP grew its holdings by 11,235 shares, bringing its total to 160,383 shares worth $5.42 million, marking a 7.5% increase.

Princeton Bancorp, Inc. Stock Down 12.9%

Shares of BPRN traded near $37.90 on Monday. While specific details about the company's market cap, P/E ratio, or other financial metrics were not provided, the stock's recent trading activity and insider purchases suggest ongoing interest from both individual and institutional investors.

Analysts Set New Price Targets

On February 4, 2025, Janney Montgomery Scott upgraded BPRN to a 'buy' rating, setting a price target of $35. This indicates a positive outlook from analysts, although the stock's current price is above this target.

Bottom Line

Martin Tuchman's recent purchase of BPRN shares adds to the ongoing insider buying activity at the company. Institutional investors have shown mixed actions, with some trimming and others initiating new positions. Analyst upgrades suggest a positive future outlook, though the stock currently trades above the latest price target. Investors will continue to watch these trends for potential insights into BPRN's future performance.